The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChenavari Toro Regulatory News (TORO)

Share Price Information for Chenavari Toro (TORO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.525
Bid: 0.51
Ask: 0.54
Change: 0.00 (0.00%)
Spread: 0.03 (5.882%)
Open: 0.53
High: 0.53
Low: 0.525
Prev. Close: 0.525
TORO Live PriceLast checked at -
Chenavari Toro Income is an Investment Trust

To deliver an absolute return primarily investing and trading in ABS and other structured credit investments in liquid markets, and investing in asset backed transactions including through the origination of credit portfolios.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

6 Aug 2019 07:00

RNS Number : 9655H
Chenavari Toro Income Fund Limited
06 August 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THIS ANNOUNCEMENT INCLUDES INSIDE INFORMATION

 

CHENAVARI TORO INCOME FUND LIMITED (the "Company")6 August 2019

 

 

Total voting rights

Following the Tender Offer where 9,331,940 Shares were validly tendered, the remaining Shares in issue total 361,450,000, of which 50,264,733 Shares are held in treasury. Shares held in treasury carry no voting rights, therefore the total number of voting rights in the Company will be 311,185,267. This figure may be used by shareholders and other investors as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 Enquiries:

 

Chenavari Investment Managers: Guy Goyard - 020 7245 4672, Kirstie Sumarno - 020 7259 3600J.P. Morgan Cazenove: William Simmonds - 020 7742 4000

 

 

This announcement is not an offer to sell or a solicitation of any offer to buy the securities of Chenavari Toro Income Fund Limited (the "Company") in the United States, Australia, Canada, Japan, The Republic of South Africa or in any other jurisdiction where such offer or sale would be unlawful.

 

This communication is not for publication or distribution, directly or indirectly, in or into the United States of America. This communication is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

 

The information contained in this announcement is given at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment. In particular, the proposals referred to herein are tentative and are subject to material updating, revision and amendment. No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.

 

The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events and in certain cases can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target", "believe" (or the negatives thereon) or other variations thereon or comparable terminology. These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company, including, among other things, the development of its business, trends in its operating industry, and future capital expenditures and acquisitions. In light of these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur. Each of the Company its affiliates and their respective officers, employees and agents expressly disclaim any and all liability which may be based on this announcement and any errors therein or omissions therefrom.

 

This announcement does not constitute or form part of, and should not be construed as, any offer or invitation or inducement for sale, transfer or subscription of, or any solicitation of any offer or invitation to buy or subscribe for or to underwrite, any share in the Company or to engage in investment activity (as defined by the Financial Services and Markets Act 2000) in any jurisdiction nor shall it, or any part of it, or the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction.

 

J.P. Morgan Cazenove is authorised and regulated in the United Kingdom by the Financial Conduct Authority. J.P. Morgan Cazenove is acting as Corporate Broker to the Company and no one else in connection with the proposals described in this announcement, and will not be responsible to anyone other than the Company for providing the protections afforded to clients of J.P. Morgan Cazenove or for affording advice in relation to any transaction or arrangement referred to in this announcement. This announcement does not constitute any form of financial opinion or recommendation on the part of J.P. Morgan Cazenove or any of its affiliates and is not intended to be an offer, or the solicitation of any offer, to buy or sell any securities.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAKPSEAFNEFF
Date   Source Headline
28th Feb 20225:00 pmRNSNotice of AGM
22nd Feb 202212:00 pmRNSNet Asset Value(s)
10th Feb 20225:00 pmRNSScrip Dividend Election Price
25th Jan 20225:00 pmRNSFactsheet Available - December 2021
21st Jan 20227:00 amRNSDividend Declaration
21st Jan 20227:00 amRNSNet Asset Value(s)
7th Jan 20227:00 amRNSShares in Issue
24th Dec 20217:00 amRNSAnnual Financial Report
23rd Dec 20217:00 amRNSFactsheet Available - November 2021
21st Dec 20217:00 amRNSNet Asset Value(s)
16th Dec 202110:30 amRNSConfirmation of GBP Quote Introduction
15th Dec 20212:45 pmRNSGBP Quote
3rd Dec 20217:00 amRNSScrip Dividend Election Price
26th Nov 20217:00 amRNSHolding(s) in Company
26th Nov 20217:00 amRNSHolding(s) in Company
24th Nov 20217:00 amRNSFactsheet Available - October 2021
19th Nov 20217:00 amRNSNet Asset Value(s)
21st Oct 20215:00 pmRNSFactsheet Available - September 2021
20th Oct 20217:00 amRNSDividend Declaration
19th Oct 20217:00 amRNSNet Asset Value(s)
24th Sep 20217:00 amRNSShares in Issue
22nd Sep 20217:00 amRNSDirector/PDMR Shareholding
21st Sep 20215:00 pmRNSFactsheet Available - August 2021
21st Sep 20217:00 amRNSNet Asset Value(s)
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
31st Aug 20215:00 pmRNSFactsheet Available - July 2021
27th Aug 20215:00 pmRNSScrip Dividend Election Price
27th Aug 202112:00 pmRNSNet Asset Value(s)
6th Aug 20215:00 pmRNSDirector/PDMR Shareholding
5th Aug 20217:00 amRNSShare Purchases
29th Jul 20217:00 amRNSDividend Declaration
28th Jul 20217:00 amRNSFactsheet Available - June 2021
20th Jul 20217:00 amRNSNet Asset Value(s)
2nd Jul 20217:00 amRNSHalf-year Report
30th Jun 20215:00 pmRNSFactsheet Available - May 2021
21st Jun 20217:00 amRNSDirector Declaration
21st Jun 20217:00 amRNSNet Asset Value(s)
14th Jun 20217:00 amRNSPurchase of Shares - Frederic Couderc
2nd Jun 20217:00 amRNSFactsheet Available - April 2021
26th May 20215:00 pmRNSResults of Scrip Dividend
24th May 20215:00 pmRNSNet Asset Value(s)
19th May 20217:00 amRNSScrip Dividend Election Price
30th Apr 20215:00 pmRNSFacsheet Available - March 2021
28th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSDividend Declaration
22nd Apr 20217:00 amRNSNet Asset Value(s)
13th Apr 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFactsheet Available - February 2021
22nd Mar 20217:00 amRNSResult of AGM
18th Mar 20217:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.